Gamma Biosciences

Merck KGaA to buy gene therapy tools maker for $600M
BioPharma Dive
Thu, 05/23/24 - 09:37 pm
Merck KGaA
M&A
MilliporeSigma
Gamma Biosciences
gene therapy